In conversation with... Leonardo Basso and Juan Pablo Torres

from Listen to The Lancet Infectious Diseases · host The Lancet

Leonardo Basso and Juan Pablo Torres discuss their study in The Lancet Infectious Diseases on the effectiveness and impact of the first season of Chile's national immunisation programme with nirsevimab. They discuss the evidence that led to the design and implementation of the programme, its impact on RSV burden and the Chilean health system, and lessons for other countries in the region and beyond.

Episode metadata supplied by the publisher feed · Published Jun 11, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Leonardo Basso and Juan Pablo Torres

0:00 15:27

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Infectious Diseases?

This episode is 15 minutes long.

When was this Listen to The Lancet Infectious Diseases episode published?

This episode was published on June 11, 2025.

Can I download this Listen to The Lancet Infectious Diseases episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!